Daiwa Securities Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-214
| Closed | -$15K | – | 1445 |
|
|
2022
Q3 | $15K | Hold |
214
| – | – | ﹤0.01% | 1109 |
|
|
2022
Q2 | $7K | Hold |
214
| – | – | ﹤0.01% | 1155 |
|
|
2022
Q1 | $7K | Hold |
214
| – | – | ﹤0.01% | 1155 |
|
|
2021
Q4 | $6K | Hold |
214
| – | – | ﹤0.01% | 1188 |
|
|
2021
Q3 | $5K | Buy |
214
+98
| +84% | +$2.88K | ﹤0.01% | 1185 |
|
|
2021
Q2 | $4K | Hold |
116
| – | – | ﹤0.01% | 1100 |
|
|
2021
Q1 | $5K | Hold |
116
| – | – | ﹤0.01% | 1084 |
|
|
2020
Q4 | $5K | Sell |
116
-232
| -67% | -$11.4K | ﹤0.01% | 1065 |
|
|
2020
Q3 | $19K | Buy |
348
+8
| +2% | +$508 | ﹤0.01% | 999 |
|
|
2020
Q2 | $17K | Hold |
340
| – | – | ﹤0.01% | 1036 |
|
|
2020
Q1 | $17K | Hold |
340
| – | – | ﹤0.01% | 1020 |
|
|
2019
Q4 | $27K | Sell |
340
-42
| -11% | -$2.49K | ﹤0.01% | 995 |
|
|
2019
Q3 | $19K | Buy |
382
+24
| +7% | +$1.25K | ﹤0.01% | 1000 |
|
|
2019
Q2 | $19K | Hold |
358
| – | – | ﹤0.01% | 1016 |
|
|
2019
Q1 | $19K | Buy |
358
+117
| +49% | +$5.75K | ﹤0.01% | 995 |
|
|
2018
Q4 | $10K | Hold |
241
| – | – | ﹤0.01% | 1001 |
|
|
2018
Q3 | $9K | Hold |
241
| – | – | ﹤0.01% | 1053 |
|
|
2018
Q2 | $11K | Hold |
241
| – | – | ﹤0.01% | 1050 |
|
|
2018
Q1 | $12K | Buy |
+241
| New | +$13.4K | ﹤0.01% | 1020 |
|
Other funds holding GBT
Daiwa Securities Group's GBT Position: Q4 2022 in Review
Daiwa Securities Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 214 shares — an estimated $15K sold.
Daiwa Securities Group first reported a position in GBT in Q1 2018 and held it in 19 quarters. The position peaked at $27K in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Daiwa Securities Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Daiwa Securities Group sold 214 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $15K.
- Daiwa Securities Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 19 quarters.
- Daiwa Securities Group's Global Blood Therapeutics, Inc. position peaked at $27K in Q4 2019.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.